Close
  Indian J Med Microbiol
 

Figure 3: Lycopene potently prolonged the survival time of prostatic carcinoma mice model in vivo. There prostatic carcinoma cell lines ([a] LNCaP, [b] PC3, and [c] DU145 cells) were injected with 1 × 105 cells into the left foreleg in mice. Then the model mice were treated with different concentration (0, 1, 5, or 10 mg kg−1) of lycopene by gavage once per day for 7 days and the survival was monitored to up to 180 days. The survival time was calculated after each mouse was dead suffering sick, moribund and skinny (n = 10). P < 0.001, groups treated with lycopene versus control (0 mg kg-1).

Figure 3: Lycopene potently prolonged the survival time of prostatic carcinoma mice model <i>in vivo</i>. There prostatic carcinoma cell lines ([<b>a</b>] LNCaP, [<b>b</b>] PC3, and [<b>c</b>] DU145 cells) were injected with 1 × 10<sup>5</sup> cells into the left foreleg in mice. Then the model mice were treated with different concentration (0, 1, 5, or 10 mg kg<sup>−1</sup>) of lycopene by gavage once per day for 7 days and the survival was monitored to up to 180 days. The survival time was calculated after each mouse was dead suffering sick, moribund and skinny (<i>n</i> = 10). <i>P</i> < 0.001, groups treated with lycopene versus control (0 mg kg<sup>-1</sup>).